Centre Hépatobiliaire, Hôpital Paul Brousse, Assistance Publique-Hôpitaux de Paris, Université Paris XI, Paris, France.
J Gastrointest Surg. 2013 Mar;17(3):593-605. doi: 10.1007/s11605-012-2048-6. Epub 2012 Nov 18.
Liver failure after hepatectomy remains the most feared postoperative complication. Many risk factors are already known, related to patient's comorbidities, underlying liver disease, received treatments and type of resection. Preoperative assessment of functional liver reserve must be a priority for the surgeon.
Physiopathology of post-hepatectomy liver failure is not comparable to fulminant liver failure. Liver regeneration is an early phenomenon whose cellular mechanisms are beginning to be elucidated and allowing most of the time to quickly recover a functional organ. In some cases, microscopic and macroscopic disorganization appears. The hepatocyte hyperproliferation and the asynchronism between hepatocytes and non-hepatocyte cells mitosis probably play a major role in this pathogenesis.
Many peri- or intra-operative techniques try to prevent the occurrence of this potentially lethal complication, but a better understanding of involved mechanisms might help to completely avoid it, or even to extend the possibilities of resection.
Future prevention and management may include pharmacological slowing of proliferation, drug or physical modulation of portal flow to reduce shear-stress, stem cells or immortalized hepatocytes injection, and liver bioreactors. Everything must be done to avoid the need for transplantation, which remains today the most efficient treatment of liver failure.
肝切除术后肝功能衰竭仍然是最令人恐惧的术后并发症。许多风险因素已经被认识到,与患者的合并症、潜在的肝脏疾病、所接受的治疗和切除类型有关。外科医生必须优先对功能性肝储备进行术前评估。
肝切除术后肝功能衰竭的病理生理学与暴发性肝功能衰竭不可比。肝再生是一个早期现象,其细胞机制开始被阐明,并允许在大多数情况下快速恢复一个功能性器官。在某些情况下,会出现微观和宏观的组织紊乱。肝细胞的过度增殖以及肝细胞和非肝细胞细胞有丝分裂的不同步可能在这一发病机制中起主要作用。
许多围手术期或术中技术试图预防这种潜在致命并发症的发生,但对相关机制的更好理解可能有助于完全避免这种并发症,甚至扩大切除的可能性。
未来的预防和管理可能包括药物抑制增殖、药物或物理调节门脉血流以降低剪切力、干细胞或永生化肝细胞注射以及肝脏生物反应器。为了避免需要进行移植,一切都必须做好,移植仍然是目前治疗肝功能衰竭最有效的方法。